<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04310514</url>
  </required_header>
  <id_info>
    <org_study_id>04-0532/09/776</org_study_id>
    <nct_id>NCT04310514</nct_id>
  </id_info>
  <brief_title>Effects of Rehydration During Physical Exercise on Acute Kidney Injury Biomarkers</brief_title>
  <official_title>Effects of Rehydration During Physical Exercise on Acute Kidney Injury Biomarkers</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University of Gdansk</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medical University of Gdansk</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Rehydration during and after physical exercise is essential to avoid acute kidney injury.

      Soft drinks are commonly used during exercise. High intake of carbohydrates is leading to
      obesity and metabolic disorders. Fructose intake is leading to uric acid abnormalities and
      kidney injury.

      30 healthy soccer players will be studied. During four training sessions subjects will intake
      500 ml 7% soft drinks containing glucose, fructose, saccharose or xylitol.

      Changes in acute kidney injury markers, markers of kidney tubular function as well as changes
      in CRP, glucose, cholesterol and uric acid levels will be studied..
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 9, 2020</start_date>
  <completion_date type="Anticipated">December 31, 2020</completion_date>
  <primary_completion_date type="Anticipated">September 1, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in urinary AKI biomarkers (urianry NGAL, urinary KIM -1, urinary cystatin-C) after physical exercise</measure>
    <time_frame>after 60-90 min of pysical exercise</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Changes in fractional uric acid excretion</measure>
    <time_frame>after 60-90 min of pysical exercise</time_frame>
  </primary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Acute Kidney Injury</condition>
  <arm_group>
    <arm_group_label>Experimental: glucose - fructose - xylitol - saccharose</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>glucose 35 g (500ml of 7% solution);
fructose 35 g (500ml of 7% solution);
xylitol 35 g (500ml of 7% solution);
saccharose 35 g (500ml of 7% solution)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Experimental: fructose - glucose - saccharose - xylitol</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>glucose 35 g (500ml of 7% solution);
fructose 35 g (500ml of 7% solution);
xylitol 35 g (500ml of 7% solution);
saccharose 35 g (500ml of 7% solution)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Experimental: xylitol - saccharose - glucose - fructose</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>glucose 35 g (500ml of 7% solution);
fructose 35 g (500ml of 7% solution);
xylitol 35 g (500ml of 7% solution);
saccharose 35 g (500ml of 7% solution)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Experimental: saccharose - xylitol - fructose - glucose</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>glucose 35 g (500ml of 7% solution);
fructose 35 g (500ml of 7% solution);
xylitol 35 g (500ml of 7% solution);
saccharose 35 g (500ml of 7% solution)</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Fructose/glucose/xylitol/saccharose</intervention_name>
    <description>Intervention: rehydration with glucose solution. Glucose will be administered at a dose of 35 mg (500 ml of 7% solution) taken orally once, in the middle of soccer training session, at approximately 10.00 a.m.
Intervention: rehydration with fructose solution. Fructose will be administered at a dose of 35 mg (500 ml of 7% solution) taken orally once, in the middle of soccer training session, at approximately 10.00 a.m.
Intervention: rehydration with xylitol solution. Xylitol will be administered at a dose of 35 mg (500 ml of 7% solution) taken orally once, in the middle of soccer training session, at approximately 10.00 a.m.
Intervention: rehydration with sucrose solution Saccharose will be administered at a dose of 35 mg (500 ml of 7% solution) taken orally once, in the middle of soccer training session, at approximately 10.00 a.m.</description>
    <arm_group_label>Experimental: fructose - glucose - saccharose - xylitol</arm_group_label>
    <arm_group_label>Experimental: glucose - fructose - xylitol - saccharose</arm_group_label>
    <arm_group_label>Experimental: saccharose - xylitol - fructose - glucose</arm_group_label>
    <arm_group_label>Experimental: xylitol - saccharose - glucose - fructose</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age above 18 years

          -  well-trained soccer players

          -  informed consent

        Exclusion Criteria:

          -  chronic diseases, especially kidney problems

          -  sigificant changes in urinalysis

          -  creatinine level above normal values
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Marcin Renke, prof</last_name>
    <role>Study Chair</role>
    <affiliation>Medical University of Gdansk</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Wojciech Wolyniec, MD,PhD</last_name>
    <phone>48 600942998</phone>
    <email>wolyniecwojtek@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Medical University of Gdansk</name>
      <address>
        <city>Gda≈Ñsk</city>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>Poland</country>
  </location_countries>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>March 9, 2020</study_first_submitted>
  <study_first_submitted_qc>March 16, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">March 17, 2020</study_first_posted>
  <last_update_submitted>March 16, 2020</last_update_submitted>
  <last_update_submitted_qc>March 16, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 17, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Medical University of Gdansk</investigator_affiliation>
    <investigator_full_name>Wojciech Wolyniec</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>biomarker</keyword>
  <keyword>albuminuria</keyword>
  <keyword>uric acid</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acute Kidney Injury</mesh_term>
    <mesh_term>Wounds and Injuries</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

